APVO

APTEVO THERAPEUTICS INC

APVO·03835L108·US·Common Stock·Healthcare - Biotechnology

APVO (APTEVO THERAPEUTICS INC) is held by 7 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($56,446), GEODE CAPITAL MANAGEMENT, LLC ($48,044), VANGUARD FIDUCIARY TRUST CO ($18,390). Net institutional sentiment: Mixed.

7
Holders
$127,860
Total Value
33% (3)
Consensus
1 buying - 2 selling
13F: Insider & Congress: Updated regularly
APVO

Smart Money Verdict

View all
Loading verdict
Held by 7 funds

Who's Trading

Source dates: Price Oct 12, 2026 · Insiders Aug 10, 2026 · Activists none · Congress none

InsiderKLKunz Barbara LopezExercise 400 shAug 6, 2026
InsiderWLWhite Marvin LTax 406 shAug 6, 2026
InsiderWLWhite Marvin LExercise 2K shAug 6, 2026
Checking access…

Top Holders

Checking access…
Action
Unchanged
12,713$56,4460.0%-56.99%
0
Decreased
10,821(-18.9%)$48,0440.0%-56.99%
0
Unchanged
4,142$18,3900.0%-72.43%
0
Decreased
730(-78.8%)$3,2420.0%-59.40%
0
Unchanged
360$1,5960.0%-80.44%
0
New
31$1380.0%-58.64%
17
Unchanged
1$40.0%-80.44%
0
APVOAPVOAPTEVO THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used